A Trial Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin in Children With Growth Hormone Deficiency
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2019
Price : $35 *
At a glance
- Drugs Somapacitan (Primary) ; Somatrogon
- Indications Somatotropin deficiency
- Focus Registrational; Therapeutic Use
- Acronyms REAL4
- Sponsors Novo Nordisk
- 21 May 2019 Status changed from not yet recruiting to recruiting.
- 18 Jan 2019 Status changed from planning to not yet recruiting.
- 17 Aug 2018 New trial record